Nature of the Event
Intimation of the grant of Employee Stock Options (ESOPs) under the Ather Energy ESOP 2025 plan, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Quantitative Figures
- Total number of ESOPs granted: 6,24,630
- Face value of underlying shares: ₹1 (Rupees One) each
- Exercise Price per ESOP: ₹1 (Rupees One)
Dates of Action
- Date of NRC approval and grant: June 23, 2026
Parties or Entities Involved
- Grantor: Ather Energy Limited (the Company)
- Grantee: Eligible employees of the Company
- Approving Authority: The Nomination and Remuneration Committee (NRC) of the Board of Directors
- Regulatory Recipients: National Stock Exchange of India Ltd (Scrip Symbol: ATHERENERG) and BSE Limited (Scrip Code: 544397)
Purpose or Stated Rationale
The grant is part of the company's employee compensation and incentive plan.
Significant Terms of the Grant (from Annexure A)
- Exercise Period: A period of five years from the date of vesting.
- Conversion: Each vested option confers a right to apply for one equity share of the Company.
- Governance: The ESOP Plan is administered by the Nomination and Remuneration Committee and is governed by the plan approved by the shareholders.
Financial or Operational Impact
- The grant represents a potential future equity dilution of 624,630 shares upon full exercise of all options.
- The monetary realization upon exercise, if all options are exercised, would be ₹624,630.
Capital Structure Impact
- The disclosure states that fields for 'Options vested', 'Options exercised', 'Money realized', 'Total number of shares arising from exercise', 'Options lapsed', 'Variation of terms', and 'Diluted earnings per share' are marked 'Not applicable' as the disclosure pertains only to the grant of options.
Additional Information
- The intimation was signed by Puja Aggarwal, Company Secretary and Compliance Officer (Membership No: A49310), on behalf of Ather Energy Limited.
#Tags: #AtherEnergy #ESOP #SEBIDisclosure #RegulatoryCompliance #CorporateGovernance #Neutral